SMTL ID : 3dkg.1

Structure of Mutant(Y1248L) MET receptor tyrosine kinase in complex with inhibitor SGX-523

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.91 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 7 residues within 4Å: Chain A: T.132, V.133, K.134, F.299, G.301, E.302, H.303 Ligand excluded by PLIP

1 x SX8: 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline(Non-covalent)

SX8.2: 15 residues within 4Å: Chain A: I.39, A.63, L.95, L.112, P.113, Y.114, M.115, D.119, N.122, R.163, N.164, M.166, A.176, D.177, A.181 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.39, A:A.63, A:L.112, A:A.176, A:D.177 Hydrogen bonds: A:M.115, A:D.177 Water bridges: A:D.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buchanan, S.G. et al., SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. Mol.Cancer Ther. (2009)

Release Date

2009-07-07

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor